Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Quadruple Marker Test- Beckman (Benetech) is 7 days.

What are the prerequisites for the test Quadruple Marker Test- Beckman (Benetech)

  • Patient should be pregnant and between 16-20 weeks of gestation
  • Doctor's prescription for the test
  • Proper identification of the patient
  • Consent form signed by the patient
  • No restrictions on food intake prior to the test
  • No specific preparation required before the test

What are the measure values for the test Quadruple Marker Test- Beckman (Benetech)

  • Alpha-fetoprotein (AFP) - measured in ng/mL
  • Unconjugated estriol (uE3) - measured in ng/mL
  • Human chorionic gonadotropin (hCG) - measured in mIU/mL
  • Inhibin-A - measured in pg/mL

What does this test Quadruple Marker Test- Beckman (Benetech) identify?

  • Quadruple Marker Test- Beckman (Benetech)
  • This test identifies the following markers:
  • 1. Alpha-fetoprotein (AFP): Elevated levels of AFP may indicate neural tube defects, such as spina bifida, or chromosomal abnormalities like Down syndrome.
  • 2. Unconjugated Estriol (uE3): Low levels of uE3 may be associated with an increased risk of fetal chromosomal abnormalities.
  • 3. Human Chorionic Gonadotropin (hCG): Abnormal levels of hCG may indicate a higher risk of chromosomal abnormalities or pregnancy complications.
  • 4. Inhibin A: Elevated levels of Inhibin A may be linked to an increased risk of chromosomal abnormalities or fetal growth restriction.

Why is this test Quadruple Marker Test- Beckman (Benetech) taken?

The Quadruple Marker Test- Beckman (Benetech) is taken to assess the risk of certain genetic abnormalities in the fetus during pregnancy. This test is typically recommended for pregnant women who are at a higher risk for genetic disorders, such as women over the age of 35 or those with a family history of genetic conditions.

The test examines levels of four specific markers in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. Abnormal levels of these markers may indicate an increased risk of conditions such as Down syndrome, Trisomy 18, or neural tube defects in the fetus.

Results from the Quadruple Marker Test can help healthcare providers and parents make informed decisions about further testing or treatment options. It is important to note that this test is not diagnostic and may only indicate a likelihood of certain genetic conditions, requiring additional testing for confirmation.

Popular FAQs on Test

The Quadruple Marker Test is a blood test that measures four specific substances in the blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), estriol, and inhibin A. These markers can provide information about the risk of certain chromosomal abnormalities and neural tube defects in a fetus.
The Quadruple Marker Test is typically performed between the 15th and 20th week of pregnancy. It is often recommended for women who are at higher risk for chromosomal abnormalities or neural tube defects based on factors such as maternal age or family history.
The Quadruple Marker Test is a safe and non-invasive test that poses minimal risk to both the mother and the fetus. It involves a simple blood draw and does not require any special preparation.
The Quadruple Marker Test is a screening test, not a diagnostic test, and therefore it is not 100% accurate. It can provide information about the likelihood of certain conditions, but further testing may be needed to confirm any potential issues.
While the Quadruple Marker Test can provide information about the risk of certain chromosomal abnormalities, it does not detect all possible genetic conditions. It is important to discuss the results with a healthcare provider to understand the implications and next steps.

Customer Google Rating